| Ad-hoc-Message due to §15 WpHG (German Securities Trading Act). Alphaform AG: With interim report for Q3 2009 |
|||
|
Feldkirchen, 4 November 2009
The business trend in 2009 has so far been dominated by the economic downturn of the economy. Group's order-intake is about 30% below the previous year. In the field of medical technologies the order intake was above last year. As before, particularly affected are the market segments automotive and Formula 1. During the third quarter Alphaform has launched a restructuring program in its traditional business, which will be completed by the end of 2009. - At €4,412,000, revenues in the third quarter of 2009 are down 16.3% on the corresponding prior-year figure of €5,272,000. Revenues for the period from 1 January to 30 September decrease by €1,373,000 or 8.6%, from €16,041,000 in 2008 to €14,668,000 in 2009. - The Group’s booked business amounts to €0.9 million as of 30 September 2009 (previous year: €1.4 million) both figures without MediMet GmbH. - EBITDA decreased from €343,000 in the third quarter of 2008 to minus €81,000 in the third quarter of 2009. In the period from 1 January to 30 September EBITDA decreased from €1,418,000 in 2008 to minus €367,000 in 2009. - Consolidated net income after interest and taxes declined year-on-year by €844,000, from €103,000 in the third quarter of 2008 to minus €741,000 in the third quarter of 2009. For the period from 1 January to 30 September, consolidated net income after interest and taxes declined by €3,048,000, from €703,000 in 2008 to minus €2,345.000 in 2009. In the first nine months of 2009 special charges incurred due to extraordinary depreciation implicated by the purchase of MediMet worth of €732,000. - Net cash from operating activities was down by €6,356,000 to minus €5,441,000 in the first nine months of 2009 compared to €915,000 in the first nine months of 2008 (thereof € minus 4.287.000 in connection with the acquisition of MediMet). - The number of employees on the reporting date 30 September 2009 is 213, thereof 58 MediMet GmbH (previous year: 157 employees without MediMet GmbH). We assume that investment activities of our customers in the traditional Alphaform business remain at low level in 2009, analog to the overall economic climate. For the fourth quarter, additional costs for restructuring of the traditional business will burden the Group's earnings. The entire interim report on Q3 2009 will be published on 13 November 2009 and will be available on our website www.alphaform.de - rubric IR/Reports.
|
|||
End of Ad hoc publication © DGAP 04 November 2009 |
|||
Alphaform AG Investor Relations Tel.: 089-90 500 235 Fax: 089-90 500 1035 e-Mail: ir@alphaform.de WKN: 548795; ISIN: DE0005487953; Index: Listed on the Geregelter Markt of the Frankfurt Stock Exchange (Prime Standard); regulated unofficial trading in Berlin-Bremen, |
|||
|
|||